Immunovia announced that Philipp Mathieu has been named Chief Executive Officer and President effective immediately. Since January, Philipp has been acting Chief Executive Officer and President. Philipp Mathieu has extensive experience as an adviser on corporate strategy, M&A and capital markets transactions to healthcare and life sciences companies.

Most recently, Philipp was a Portfolio Manager and Advisor to a multinational family office. Previously, he was an investment banker focused in the Healthcare sector at Lazard and Lehman Brothers.